Literature DB >> 27278509

Concurrent Treatment of Substance Use and PTSD.

Julianne C Flanagan1, Kristina J Korte2, Therese K Killeen2, Sudie E Back2,3.   

Abstract

Substance use disorders (SUD) and posttraumatic stress disorder (PTSD) are chronic, debilitating conditions that frequently co-occur. Individuals with co-occurring SUD and PTSD suffer a more complicated course of treatment and less favorable treatment outcomes compared to individuals with either disorder alone. The development of effective psychosocial and pharmacological interventions for co-occurring SUD and PTSD is an active and critically important area of investigation. Several integrated psychosocial treatments for co-occurring SUD and PTSD have demonstrated promising outcomes. While recent studies examining medications to treat co-occurring SUD and PTSD have yielded encouraging findings, there remain substantial gaps in the evidence base regarding the treatment of co-occurring SUD and PTSD. This review will summarize the findings from clinical trials targeting a reduction in SUD and PTSD symptoms simultaneously. These results may improve our knowledge base and subsequently enhance our ability to develop effective interventions for this complex comorbid condition.

Entities:  

Keywords:  Addiction; Clinical trials; Integrated intervention; Posttraumatic stress disorder; Substance use disorders

Mesh:

Year:  2016        PMID: 27278509      PMCID: PMC4928573          DOI: 10.1007/s11920-016-0709-y

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  87 in total

Review 1.  Psychological treatments for concurrent posttraumatic stress disorder and substance use disorder: a systematic review.

Authors:  Debora van Dam; Ellen Vedel; Thomas Ehring; Paul M G Emmelkamp
Journal:  Clin Psychol Rev       Date:  2012-02-10

2.  Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus.

Authors:  Dean S Carson; Glenn E Hunt; Adam J Guastella; Lachlan Barber; Jennifer L Cornish; Jonathon C Arnold; Aurelie A Boucher; Iain S McGregor
Journal:  Addict Biol       Date:  2010-08-23       Impact factor: 4.280

Review 3.  Amygdala, medial prefrontal cortex, and hippocampal function in PTSD.

Authors:  Lisa M Shin; Scott L Rauch; Roger K Pitman
Journal:  Ann N Y Acad Sci       Date:  2006-07       Impact factor: 5.691

4.  The story of glutamate in drug addiction and of N-acetylcysteine as a potential pharmacotherapy.

Authors:  Robyn M Brown; Yonatan M Kupchik; Peter W Kalivas
Journal:  JAMA Psychiatry       Date:  2013-09       Impact factor: 21.596

5.  A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder.

Authors:  Tracy L Simpson; Carol A Malte; Bergetta Dietel; Dana Tell; Ian Pocock; Robert Lyons; Dana Varon; Murray Raskind; Andrew J Saxon
Journal:  Alcohol Clin Exp Res       Date:  2015-04-01       Impact factor: 3.455

6.  Substance use comorbidity among veterans with posttraumatic stress disorder and other psychiatric illness.

Authors:  Ismene L Petrakis; Robert Rosenheck; Rani Desai
Journal:  Am J Addict       Date:  2011-03-17

7.  Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial.

Authors:  Steven L Batki; David L Pennington; Brooke Lasher; Thomas C Neylan; Thomas Metzler; Angela Waldrop; Kevin Delucchi; Ellen Herbst
Journal:  Alcohol Clin Exp Res       Date:  2014-08-04       Impact factor: 3.455

8.  Subsyndromal posttraumatic stress disorder is associated with health and psychosocial difficulties in veterans of Operations Enduring Freedom and Iraqi Freedom.

Authors:  Robert H Pietrzak; Marc B Goldstein; James C Malley; Douglas C Johnson; Steven M Southwick
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

9.  Treatment of alcohol abuse: an evidence-based review.

Authors:  Mats Berglund; Sten Thelander; Mikko Salaspuro; Johan Franck; Sven Andréasson; Agneta Ojehagen
Journal:  Alcohol Clin Exp Res       Date:  2003-10       Impact factor: 3.455

Review 10.  Pharmacological treatment of comorbid PTSD and substance use disorder: recent progress.

Authors:  Mehmet Sofuoglu; Robert Rosenheck; Ismene Petrakis
Journal:  Addict Behav       Date:  2013-08-22       Impact factor: 3.913

View more
  24 in total

1.  Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE): A Pilot Study in Alcohol-dependent Women.

Authors:  Anna Persson; Sudie E Back; Therese K Killeen; Kathleen T Brady; Melanie L Schwandt; Markus Heilig; Åsa Magnusson
Journal:  J Addict Med       Date:  2017 Mar/Apr       Impact factor: 3.702

2.  Habituation of distress and craving during treatment as predictors of change in PTSD symptoms and substance use severity.

Authors:  Christal L Badour; Julianne C Flanagan; Daniel F Gros; Therese Killeen; Irene Pericot-Valverde; Kristina J Korte; Nicholas P Allan; Sudie E Back
Journal:  J Consult Clin Psychol       Date:  2017-03

3.  PTSD Symptom Clusters and Craving Differs by Primary Drug of Choice.

Authors:  Vanessa C Somohano; Kristoffer L Rehder; Tyree Dingle; Taylor Shank; Sarah Bowen
Journal:  J Dual Diagn       Date:  2019-07-14

4.  Prevalence and Correlates of Disability Among a Sample of Victimized Women on Probation and Parole.

Authors:  Kirsten E Smith; Amanda M Bunting; Seana Golder; Martin T Hall; George E Higgins; T K Logan
Journal:  J Correct Health Care       Date:  2019-03-13

5.  Substance use disorders and PTSD: Examining substance use, PTSD symptoms, and dropout following imaginal exposure.

Authors:  Amber M Jarnecke; Nicholas P Allan; Christal L Badour; Julianne C Flanagan; Therese K Killeen; Sudie E Back
Journal:  Addict Behav       Date:  2018-10-16       Impact factor: 3.913

6.  Posttraumatic Stress Disorder in Patients with Heavy Alcohol Consumption and Alcoholic Hepatitis.

Authors:  Niharika Samala; Spencer G Lourens; Vijay H Shah; Patrick S Kamath; Arun J Sanyal; David W Crabb; Qing Tang; Svetlana Radaeva; Suthat Liangpunsakul; Naga Chalasani
Journal:  Alcohol Clin Exp Res       Date:  2018-08-26       Impact factor: 3.455

7.  Service providers' perceptions of barriers to the implementation of trauma-focused substance use services for women in Cape Town, South Africa.

Authors:  Bronwyn Myers; Tara Carney; Kim Johnson; Felicia A Browne; Wendee M Wechsberg
Journal:  Int J Drug Policy       Date:  2019-12-09

Review 8.  Adolescent Substance Use Disorder Treatment: an Update on Evidence-Based Strategies.

Authors:  Matthew C Fadus; Lindsay M Squeglia; Emilio A Valadez; Rachel L Tomko; Brittany E Bryant; Kevin M Gray
Journal:  Curr Psychiatry Rep       Date:  2019-09-14       Impact factor: 5.285

9.  The Role of Affect in Psychosocial Treatments for Substance Use Disorders.

Authors:  Julia E Swan; Victoria R Votaw; Elena R Stein; Katie Witkiewitz
Journal:  Curr Addict Rep       Date:  2020-06-01

10.  Posttraumatic Stress Disorder Symptomatology and Substance Use in an Outpatient Concurrent Disorders Sample.

Authors:  Herry Patel; Katherine Holshausen; Assaf Oshri; Krysta Andrews; Stephanie Penta; Holly Raymond; Margaret McKinnon; Jennifer Brasch; James MacKillop; Michael Amlung
Journal:  Can J Psychiatry       Date:  2021-04-20       Impact factor: 4.356

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.